Asset Details
Do you wish to reserve the book?
Agonists and Inhibitors of the cGAS-STING Pathway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Agonists and Inhibitors of the cGAS-STING Pathway
Do you wish to request the book?
Agonists and Inhibitors of the cGAS-STING Pathway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Agonists and Inhibitors of the cGAS-STING Pathway
2024
Overview
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is pivotal in immunotherapy. Several agonists and inhibitors of the cGAS-STING pathway have been developed and evaluated for the treatment of various diseases. The agonists aim to activate STING, with cyclic dinucleotides (CDNs) being the most common, while the inhibitors aim to block the enzymatic activity or DNA binding ability of cGAS. Meanwhile, non-CDN compounds and cGAS agonists are also gaining attention. The omnipresence of the cGAS-STING pathway in vivo indicates that its overactivation could lead to undesired inflammatory responses and autoimmune diseases, which underscores the necessity of developing both agonists and inhibitors of the cGAS-STING pathway. This review describes the molecular traits and roles of the cGAS-STING pathway and summarizes the development of cGAS-STING agonists and inhibitors. The information is supposed to be conducive to the design of novel drugs for targeting the cGAS-STING pathway.
Publisher
MDPI AG
Subject
/ Agonists
/ Animals
/ Antigens
/ Autoimmune Diseases - drug therapy
/ Autoimmune Diseases - metabolism
/ Humans
/ Kinases
/ Membrane Proteins - agonists
/ Membrane Proteins - antagonists & inhibitors
/ Membrane Proteins - metabolism
/ Nucleotidyltransferases - antagonists & inhibitors
/ Nucleotidyltransferases - metabolism
/ Proteins
/ Signal Transduction - drug effects
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.